Copied
Induction with Infliximab and a Plant-Based Diet as First-Line (IPF) Therapy for Crohn Disease: A Single-Group Trial
Abstract
Details
Title
Induction with Infliximab and a Plant-Based Diet as First-Line (IPF) Therapy for Crohn Disease: A Single-Group Trial
Type of Article
Primary Research
Diets studied
Whole Foods Plant Based
Date
October 6, 2017
Author(s)
Chiba M et al
Publication
The Permanente Journal
Citation
Chiba, M., Tsuji, T., Nakane, K., Tsuda, S., Ishii, H., Ohno, H., Watanabe, K., Ito, M., Komatsu, M., & Sugawara, T. (2017). Induction with Infliximab and a Plant-Based Diet as First-Line (IPF) Therapy for Crohn Disease: A Single-Group Trial. The Permanente Journal, 21(4), 17–009. https://doi.org/10.7812/TPP/17-009
ISSN Number
1552-5767, 1552-5775
Volume
21
Pages
17-009
IPF therapy can induce remission in most patients with CD who are naïve to biologics regardless of age or whether they have a new diagnosis or relapse.
Support our Mission
Your donation will help us to enhance the well-being and health outcomes of patients with IBD.
Donate